Frontiers in Pharmacology | Cardiovascular and Smooth Muscle Pharmacology

Review

Published on 14 Jun 2024

Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects

in Cardiovascular and Smooth Muscle Pharmacology

Maria Antonietta Riemma
Elena Mele
Maria Donniacuo
Marialucia Telesca
Gabriella Bellocchio
Giuseppe Castaldo
Francesco Rossi
Antonella De Angelis
Donato Cappetta
Konrad Urbanek

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1422740

6,220 views
7 citations

Original Research

Published on 13 Jun 2024

Addition of eptifibatide and manual thrombus aspiration to ticagrelor does not improve long-term survival after STEMI treated with primary PCI

in Cardiovascular and Smooth Muscle Pharmacology

Paul-Adrian Călburean
Paul Grebenișan
Ioana-Andreea Nistor
Krisztina Pal
Victor Vacariu
Reka-Katalin Drincal
Alissa Anamaria Ion
István Adorján
Tiberiu Oltean
László Hadadi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1415025

2,096 views
12 citations

Review

Published on 13 Jun 2024

Dialogue between mitochondria and endoplasmic reticulum-potential therapeutic targets for age-related cardiovascular diseases

in Cardiovascular and Smooth Muscle Pharmacology

Chen Chen
Xueyan Dong
Wang Zhang
Xing Chang
Wulin Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389202

7,072 views
12 citations

Original Research

Published on 12 Jun 2024

Efficacy and safety of rivaroxaban versus warfarin in the management of unusual site deep vein thrombosis: a retrospective cohort study

in Cardiovascular and Smooth Muscle Pharmacology

Linlin Fu
Wenting Cai
Hanyang Li
Dan Han
Li Li
Baoyan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1419985

2,685 views
6 citations

Review

Published on 11 Jun 2024

Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome

in Cardiovascular and Smooth Muscle Pharmacology

Wei-Dong Sun
Xiao-Juan Zhu
Jing-Jing Li
Ya-Zhong Mei
Wen-Song Li
Jiang-Hua Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1410479

11,858 views
21 citations

Mini Review

Published on 10 Jun 2024

PDE4 inhibitors: potential protective effects in inflammation and vascular diseases

in Cardiovascular and Smooth Muscle Pharmacology

Tianfei Fan
Wenjing Wang
Yao Wang
Mingtang Zeng
Yi Liu
Shuyao Zhu
Lin Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1407871

15,697 views
29 citations

Review

Published on 05 Jun 2024

Inhibition of differentiation of monocyte-derived macrophages toward an M2-Like phenotype May Be a neglected mechanism of β-AR receptor blocker therapy for atherosclerosis

in Cardiovascular and Smooth Muscle Pharmacology

Shouyi Liu
Bo Zhang
Jingqun Zhou
Jianfeng Lv
Jinxia Zhang
Xiangyan Li
Weihua Yang
Yuanlin Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1378787

2,353 views

Original Research

Published on 31 May 2024

Celastrol alleviates diabetic vascular injury via Keap1/Nrf2-mediated anti-inflammation

in Cardiovascular and Smooth Muscle Pharmacology

Ning An
Rixiang Wang
Lin Li
Bingyu Wang
Huiting Wang
Ganyu Peng
Hua Zhou
Gen Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1360177

4,059 views
4 citations

Original Research

Published on 28 May 2024

Quantifying fetal heart health in gestational diabetes: a new approach with fetal heart quantification technology

in Cardiovascular and Smooth Muscle Pharmacology

Pengjie Zhang
Xinghui Fu
Lijuan Zhao
Lu Wang
Shuning Wu
Yanyan Liu
Jingliang Cheng
Shan Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1394885

2,877 views
5 citations

Original Research

Published on 27 May 2024

Cardiac sympathetic overdrive, M2 macrophage activation and fibroblast heterogeneity are associated with cardiac remodeling in a chronic pressure overload rat model of HFpEF

in Cardiovascular and Smooth Muscle Pharmacology

Fengjiao Sun
Ling Yuan
Zi Wang
Xiaoxue Cui
Nan Lv
Ting Zhang
Yan Zhang
Jun Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1364758

4,498 views
6 citations

Original Research

Published on 21 May 2024

Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes

in Cardiovascular and Smooth Muscle Pharmacology

Celestino Sardu
Ludovica Vittoria Marfella
Valerio Giordano
Caterina Claudia Lepre
Giovanbattista D’Amico
Mario Volpicelli
Carla Contaldi
Raffaele Galiero
Alfredo Caturano
Flavia Casolaro

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1402782

2,650 views
2 citations

Review

Published on 17 May 2024

The structure and function of FUN14 domain-containing protein 1 and its contribution to cardioprotection by mediating mitophagy

in Cardiovascular and Smooth Muscle Pharmacology

Yuhu Lv
Zhengze Yu
Peiwen Zhang
Xiqian Zhang
Huarui Li
Ting Liang
Yanju Guo
Lin Cheng
Fenglin Peng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389953

3,821 views
3 citations

Original Research

Published on 17 May 2024

Research trends in lipid-lowering therapies for coronary heart disease combined with hyperlipidemia: a bibliometric study and visual analysis

in Cardiovascular and Smooth Muscle Pharmacology

Quankai Cheng
Jingjing Sun
Haicheng Zhong
Ziming Wang
Chang Liu
Sheng Zhou
Jie Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1393333

6,832 views
7 citations

Original Research

Published on 10 May 2024

Combination of ADAM17 knockdown with eplerenone is more effective than single therapy in ameliorating diabetic cardiomyopathy

in Cardiovascular and Smooth Muscle Pharmacology

Lin Xie
Dejin Zang
Jianmin Yang
Fei Xue
Wenhai Sui
Yun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1364827

3,213 views
4 citations

Review

Published on 10 May 2024

Thromboembolic prevention in athletes: management of anticoagulation in sports players affected by atrial fibrillation

in Cardiovascular and Smooth Muscle Pharmacology

Simona Minardi
Luigi Sciarra
Antonio Gianluca Robles
Antonio Scara
Francesco Sciarra
Gabriele De Masi De Luca
Silvio Romano

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1384213

3,779 views
5 citations

Review

Published on 09 May 2024

O-GlcNAcylation in ischemic diseases

in Cardiovascular and Smooth Muscle Pharmacology

Rui-Rui Shi
Tian-Qi He
Meng-Si Lin
Jian Xu
Jin-Hua Gu
Hui Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377235

4,479 views
3 citations

Original Research

Published on 03 May 2024

Cardiovascular adverse events associated with antibody-drug conjugates (ADCs): a pharmacovigilance study based on the FAERS database

in Cardiovascular and Smooth Muscle Pharmacology

PingPing Long
Siyu Li
Lingyun Pan
Yuanqiang Wang
Wanyi Chen
Xiaoxiao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1378010

16,941 views
12 citations

Case Report

Published on 01 May 2024

Case report: Successful anesthesia management of noncardiac surgery in a patient with single atrium

in Cardiovascular and Smooth Muscle Pharmacology

Hong Cao
Mengmeng Jiang
Zhao Zhuang
Shoushi Wang
Qianqian Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1370263

2,573 views
1 citation

Editorial

Published on 29 Apr 2024

Editorial: Recent advances in cardiotoxicity testing, volume II

in Cardiovascular and Smooth Muscle Pharmacology

Abou-Bakr M. Salama
Tamer M. A. Mohamed

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1414373

2,142 views

Case Report

Published on 26 Apr 2024

Ascorbic acid-induced warfarin resistance after breast cancer surgery: a case report and literature review

in Cardiovascular and Smooth Muscle Pharmacology

Pingfa Gao
Yang Shen
Ping Wu
Wenjie Lv

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1390996

3,776 views
1 citation

Original Research

Published on 25 Apr 2024

Noninvasive cardiac-specific biomarkers for the diagnosis and prevention of vascular stenosis in cardiovascular disorder

in Cardiovascular and Smooth Muscle Pharmacology

Sujith Kumar Pulukool
Sai Krishna Srimadh Bhagavatham
Sudarshan K. Vijay
Abdulrahman I. Almansour
Sandeep Chaudhary
Farah Abuyousef
Na’il Saleh
Pratima Tripathi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376226

3,473 views
3 citations

Review

Published on 24 Apr 2024

Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease

in Cardiovascular and Smooth Muscle Pharmacology

Tianyu Wang
Juncan Ding
Xinyi Cheng
Qiang Yang
Pengfei Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1396656

6,203 views
11 citations

Review

Published on 18 Apr 2024

Non-coding RNAs as regulators of the Hippo pathway in cardiac development and cardiovascular disease

in Cardiovascular and Smooth Muscle Pharmacology

Mengyang Song
He Wang
Caixia Liu
Sijie Jin
Bin Liu
Wei Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1348280

6,306 views
5 citations

Review

Published on 12 Apr 2024

NLRP3 inflammasome and pyroptosis in cardiovascular diseases and exercise intervention

in Cardiovascular and Smooth Muscle Pharmacology

Ping Ding
Yuanming Song
Yang Yang
Cheng Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1368835

6,299 views
15 citations

1,410 articles

articles

Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects

Addition of eptifibatide and manual thrombus aspiration to ticagrelor does not improve long-term survival after STEMI treated with primary PCI

Dialogue between mitochondria and endoplasmic reticulum-potential therapeutic targets for age-related cardiovascular diseases

Efficacy and safety of rivaroxaban versus warfarin in the management of unusual site deep vein thrombosis: a retrospective cohort study

Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome

PDE4 inhibitors: potential protective effects in inflammation and vascular diseases

Inhibition of differentiation of monocyte-derived macrophages toward an M2-Like phenotype May Be a neglected mechanism of β-AR receptor blocker therapy for atherosclerosis

Celastrol alleviates diabetic vascular injury via Keap1/Nrf2-mediated anti-inflammation

Quantifying fetal heart health in gestational diabetes: a new approach with fetal heart quantification technology

Cardiac sympathetic overdrive, M2 macrophage activation and fibroblast heterogeneity are associated with cardiac remodeling in a chronic pressure overload rat model of HFpEF

Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes

The structure and function of FUN14 domain-containing protein 1 and its contribution to cardioprotection by mediating mitophagy

Research trends in lipid-lowering therapies for coronary heart disease combined with hyperlipidemia: a bibliometric study and visual analysis

Combination of ADAM17 knockdown with eplerenone is more effective than single therapy in ameliorating diabetic cardiomyopathy

Thromboembolic prevention in athletes: management of anticoagulation in sports players affected by atrial fibrillation

O-GlcNAcylation in ischemic diseases

Cardiovascular adverse events associated with antibody-drug conjugates (ADCs): a pharmacovigilance study based on the FAERS database

Case report: Successful anesthesia management of noncardiac surgery in a patient with single atrium

Editorial: Recent advances in cardiotoxicity testing, volume II

Ascorbic acid-induced warfarin resistance after breast cancer surgery: a case report and literature review

Noninvasive cardiac-specific biomarkers for the diagnosis and prevention of vascular stenosis in cardiovascular disorder

Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease

Non-coding RNAs as regulators of the Hippo pathway in cardiac development and cardiovascular disease

NLRP3 inflammasome and pyroptosis in cardiovascular diseases and exercise intervention